| abstract |
Kind Code: A1 The present invention relates to Na + -glucose cotransporter inhibitors, particularly therapeutic agents for non-insulin-dependent diabetes mellitus (type 2 diabetes), insulin-dependent diabetes mellitus (type 1 diabetes), insulin-resistant disease, fatty liver and obesity. And a compound useful as a prophylactic agent for the disease. A benzene ring is difluoromethylene (-CF 2 -) via, coupled with another benzene ring, the benzene ring is characterized by binding directly to the sugar residue, difluoro diphenylmethane derivatives and salt. [Selection diagram] None |